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Abstract Alcohol consumption is postulated to be a risk
factor for pancreatic cancer (PCA), but clariﬁcation of
degree of risk related to consumption characteristics is
lacking. We examined the association between alcohol
consumption and PCA in a population-based case–control
study (532 cases, 1,701 controls) in the San Francisco Bay
Area.Population-basedcontrolswerefrequency-matchedby
sex, age within 5-year categories and county of residence to
cases identiﬁed by the cancer registry’s rapid case ascer-
tainment. Detailed alcohol consumption data, including
binge drinking (C5 drinks/day), were collected during
in-person interviews. Odds ratios (OR) and 95% conﬁdence
intervals (95% CI) were computed using adjusted uncondi-
tional logistic regression. Depending on dose, duration, and
patternofdrinking,ORswereincreased1.5-to6-foldamong
men but not women. In men, ORs increased with increasing
overallalcoholconsumption(22–35drinks/weekOR = 2.2,
95% CI = 1.1–4.0; C35 drinks/week OR = 2.6, 95%
CI = 1.3–5.1, p-trend = 0.04). Most notable were effects
with a history of binge drinking (OR = 3.5, 95% CI =
1.6–7.5) including increased number of drinks per day
(p-trend = 0.002), and increased years of binge drinking
(p-trend = 0.0006). In fully adjusted models that included
smoking and other confounders, ORs for binge drinking in
men were somewhat higher than in age-adjusted models.
Resultsfromourdetailedanalysesprovidesupportforheavy
alcohol consumption (including binge drinking) as a risk
factor for PCA in men.
Keywords Pancreatic neoplasms  Alcohol-related
disorders  Case–control studies  Risk  Epidemiology 
Alcohol drinking  Alcoholic beverages
Introduction
Pancreatic cancer is diagnosed in over 124,000 individuals
globally per year and is nearly uniformly fatal in the
developing and developed areas, with the lowest overall
5-year survival rate of all site-speciﬁc cancers [1, 2]. The
lethality of pancreatic cancer requires dedicated attention
to understanding the causes and modiﬁable risk factors
associated with development of this disease.
Alcohol has been identiﬁed inconsistently as a risk
factor for pancreatic cancer [3–42]. Particularly important
reasons for inconsistency that may have resulted in report
of no association between alcohol consumption and pan-
creatic cancer may have included incomplete assessment
and analysis of dose of alcohol consumption risk across
wide ranges, as well as pattern of alcohol consumption.
Thus, more large population-based studies are required to
examine this association while adjusting for other putative
risk factors, and considering the relationship of dose and
pattern of alcohol exposure. We conducted the current
analyses as part of a large, population-based case–control
study in the San Francisco Bay Area to examine the rela-
tionship between pancreatic cancer and alcohol consump-
tion, with particular attention to the associated exposure
characteristics of timing of consumption onset, duration,
and dose, including binge drinking.
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Detailed methods for this case–control study have been
published elsewhere [43–49]; a brief summary of methods
follows. Cases were newly diagnosed with adenocarcinoma
of the exocrine pancreas between 1995 and 1999, residents
of one of six Bay Area counties at the time of diagnosis, and
were identiﬁed using rapid case ascertainment by the
Northern California Cancer Center. Diagnoses of pancreatic
cancer were conﬁrmed by participants’ physicians and by
the Surveillance, Epidemiology and End Results abstracts
that included histologic conﬁrmation of disease when
available. Eligible cases that were included were alive at
contact (no proxy interviews were conducted), 21–85 years
of age, and able to complete an interview in English.
Control participants were selected from the same target
population as the cases using random-digit dial and were
frequency-matched to cases by sex, age within 5-year
categories and county. Identiﬁcation of controls older than
65 years was supplemented by random selection from the
United States Health-Care Finance Administration (now
the Centers for Medicare and Medicaid Services) lists.
Approximately three controls were identiﬁed for each case
participant. Sixty-seven percent of eligible cases and 67%
of eligible controls completed an in-person interview using
structured questionnaires. Written consent was obtained
from each study participant prior to the interview. This
study was reviewed and approved by the University of
California San Francisco Committee on Human Research.
Alcohol consumption
Participants self-reported their history of alcohol con-
sumption, including type of alcohol consumed (beer, wine,
and/or liquor). One drink was deﬁned as one can, bottle or
12 oz glass of beer, one 4 oz glass of wine, or one shot of
liquor because they each contain approximately 14 g of
alcohol. The average weekly consumption of beer, wine,
and liquor was recorded separately by decade of age,
starting in their 20s, i.e., 20–29, 30–39, 40–49, 50–59,
60–69, 70–79, and 80?. Lifetime total alcohol consumption
was computed by summing the total number of drinks of
beer, wine, and liquor in each decade. Average number of
drinks consumed per week in the past decade ? current
decade; the past two decades ? current decade;and the past
three decades ? current decade also were determined.
Participants also were grouped as: never drinkers, exclusive
consumers of beer, wine or liquor, and those who consumed
two or three types of alcohol. Under the a priori hypothesis
that the pattern of alcohol consumption of alcohol might be
related to pancreatic cancer, binge alcohol consumption was
assessed as frequency, volume, and duration of alcohol
consumption beyond their usual drinking patterns. For
analyses, we deﬁned ‘‘binge drinking’’ as consumption of
ﬁve or more drinks per day (70 g of alcohol), following the
deﬁnition used by the United States Behavioral Risk Factor
Surveillance System study [50, 51]. For ease of comparison,
analyses of the primary measure of risk (lifetime weekly
alcohol consumption) were conducted using categories
from an earlier similar study of pancreatic cancer and
alcohol consumption [16]. For other categories of alcohol
consumption, weekly alcohol consumption was categorized
into quartiles based on the frequency distribution among the
controls. Because binge drinking was determined separately
from usual drinking patterns, individuals who were char-
acterized as binge drinkers were distributed across the range
of quartiles of typical drinking patterns. For example, some
binge drinkers who on occasion drank ﬁve or more drinks
per day were included in lower quartiles of overall alcohol
consumption based upon the average number of drinks
typically consumed per week.
Statistical methods
Demographic data and data for potential confounders were
collected and deﬁned as follows: race was self-reported, and
categorized as white, black/African American, Asian/Paci-
ﬁc Islander, or other. Body mass index (BMI) was estimated
from usual adult weight and height [weight (kg)/height
(m
2)], and was categorized based on World Health Orga-
nization criteria:\25.0 (lean to normal), 25.0–29.9 (over-
weight), and C30.0 (obese). Frequency of recreational
physical activity for at least 30 min per episode was
recorded as never or \1/month, 1–2/month, 3–4/month,
2–3/week, 4–6/week, and C1/day. Participants were deﬁned
as smokers if they had smoked C100 cigarettes, or cigars or
pipes at least once a month for C6 months in their lifetime.
Cigarette smokers were categorized into four groups: never
smokers; former smokers (two groups) who quit[15 years
ago or 1–15 years prior to diagnosis/interview; and current
smokers including those who had quit within 1 year of
diagnosis/interview. Total caloric intake (expressed as
kilocalories per day), vitamin intake (vitamins A, B1–B12,
C, E, D), and calcium intake were estimated based on
results of a food-frequency questionnaire and divided into
quartiles based on consumption among controls as descri-
bed previously [52, 53]. Education level was categorized as
less than high school graduate, high school graduate, some
college, college graduate, and graduate work. Participants
also were asked if they ever had been told by a physician
that they had diabetes or pancreatitis. Odds ratios (OR) and
95% conﬁdence intervals (95% CI) were computed using
unconditional logistic regression to estimate the relative
risk (hereafter called risk) of pancreatic cancer by catego-
ries of alcohol consumption. The reference group for
alcohol analyses was those who never drank or drank less
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adjusted for age. Results for the association between weekly
alcohol consumption and pancreatic cancer were further
stratiﬁed by smoking status–smokers (deﬁned as cigarette,
pipe, or cigar smokers and former smokers who quit
\15 years prior to interview), versus non-smokers (deﬁned
as never smokers, or former smokers who quit C 15 years
prior to interview). Former smokers who quit C15 years
prior to interview were grouped with never smokers as our
analyses showed no association between this group and
increased pancreatic cancer risk (data not shown). Analyses
of alcohol consumption and risk restricted only to current
smokers also are provided. Because of sample size con-
straints,the referentgroup foranalyses restricted to smokers
was those who drank less than 1 drink/month over their
lifetime, or B4 drinks/week in the 20 years prior to inter-
view. Analyses stratiﬁed by type of alcohol also are pre-
sented. For comparability with other studies and our earlier
published results of data from this study, we present results
from parsimonious models adjusted for age alone, and from
multivariable models additionally adjusted for potential
confounders of race, education, smoking, history of diabe-
tes, BMI, caloric intake, and physical activity. Exploratory
analyses adjusting for history of pancreatitis also were
conducted, but results are not presented as risk estimates did
not differ by at least 10%. Odds ratios and 95% CIs are not
presented in tables when the number of observations was
ﬁve or fewer. All statistical tests were two-sided and con-
sidered statistically signiﬁcant when p\0.05. Statistical
analyses were conducted using SAS software V9.1 (SAS
Institute, Inc., Cary, NC) and results are presented for age-
adjusted and ﬁnal multivariable models.
Results
Characteristics of the study population have been reported
previously [43–49] and are noted in Table 1. Five hundred
and thirty-two eligible cases and 1,701 controls completed
in-person interviews. Alcohol consumption was associated
with pancreatic cancer among men but not women, with
increased risk ranging from 1.5- to 6-fold based on the
dose, duration, and pattern of alcohol consumption repor-
ted (Tables 2, 3). Results from more detailed analyses
pertaining to heavy drinking are limited to men (Tables 2,
3, 4, 5).
Effect of alcohol dose and duration of consumption
Among men, ORs for pancreatic cancer increased with
increasing duration and increasing dose of heavy alcohol
consumption (all p-trend\0.04, Table 2). Relative to
never or infrequent drinkers, men with the highest lifetime
alcohol consumption had a greater than twofold increased
risk of pancreatic cancer that remained elevated when
assessment of alcohol consumption was limited to the past
20 years (Table 2). Risk was elevated regardless of when
in the past the heavy consumption had occurred; ORs
ranged from 2 to 2.6 for heavy drinking in the past 10, 20,
or 30 years (data not shown). When analyses were
restricted to the heaviest drinkers, results showed that risk
increased with increasing decades of heavy consump-
tion ([21 drinks/week p-trend = 0.02, [35 drinks/week
p-trend = 0.01, Table 2).
Binge drinking and risk
Irregular pattern of heavy alcohol consumption, assessed as
binge drinking, was associated with risk of pancreatic
cancer (Table 3). A history of binge consumption of large
amounts of alcohol (C5 drinks per drinking episode or
[70 g alcohol per episode) [50, 51] conferred a 3.5-fold
increased risk of pancreatic cancer in men. Risk was
increased regardless of age when binge drinking ﬁrst
occurred, although there was some evidence that risk was
greatest for binge drinking that began at 21–30 years of age
(p-trend = 0.007). A similar pattern was observed for
years since last binge drinking episode. Risk was increased
more than threefold regardless of when binge drinking last
occurred, although men whose last binge drinking episode
occurred 6–10 years before diagnosis/interview had a
greater than sixfold increased risk of pancreatic cancer.
Dose–response analyses provided additional support that
binge drinking increased risk of pancreatic cancer in men.
Risk was positively associated with increasing average
number of alcoholic drinks consumed during binge drink-
ing ([15 drinks: OR = 4.4, p-trend = 0.002) and with
increasing years duration of binge drinking ([10 years:
OR = 3.7, p-trend = 0.0006). Risk also was persistently
increased regardless of frequency of binge drinking each
month. Indeed, there was some evidence that even less
frequent binge drinking was associated with the elevated
risk in men (OR = 4.3). In fully adjusted models that
included smoking and other confounders, ORs for binge
drinking in men were somewhat higher than in models
adjusted for age only (Table 3).
Effect of dose and pattern of alcohol consumption
stratiﬁed by smoking status
In smoking-stratiﬁed analyses of the association of alcohol
consumption with pancreatic cancer among men, most
estimates were based on a small number of exposed indi-
viduals and were imprecise with wide conﬁdence intervals
that included unity with few exceptions (Tables 4, 5). In
general, risk of pancreatic cancer was greatest in the
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of smoking status. However, results from multivariable
analyses suggested that heavy drinkers and the heaviest
binge drinkers who were current smokers may be at greater
risk of pancreatic cancer than former/never smokers
(Table 5, binge drinking [10 years OR = 9.5, 95%
CI = 1.8–50, p-trend = 0.01; C15 drinks/day during binge
drinking OR = 9.5, 95% CI = 1.4–64, p-trend = 0.01;
[35 drinks/week during the past 20 years OR = 4.2, 95%
CI = 1.6–12, p-trend = 0.002, p-interaction between
heavy drinking and smoking status[0.30).
Alcohol type and risk
Analyses of risk of pancreatic cancer stratiﬁed by type of
alcohol consumed were generally limited by sample size
considerations. Signiﬁcant associations among men by
alcohol type or combination of alcohol types were noted
for wine (OR = 2.8, 95% CI = 1.2–6.3), consumption of
beer and liquor (OR = 2.3, 95% CI = 1.3–4.1), and the
combination of beer, wine, and liquor consumption
(OR = 1.7, 95% CI = 1.0–2.8). As was observed for the
overall analyses, no association between type of alcohol
Table 1 Demographic
characteristics of pancreatic
cancer and control participants
in a population-based
case–control study in the
San Francisco Bay Area,
California 1995–1999
Percentages may not add to
100% due to rounding or
missing values
 Age at pancreatic cancer
diagnosis for cases or age at
interview for controls
Characteristics Cases (n = 532) Controls (n = 1,701)
n % n %
Age
, years
\50 46 9 164 10
50–59 120 23 438 26
60–69 172 32 473 28
70–79 158 30 498 29
80–85 36 7 128 8
Sex
Men 291 55 883 52
Women 241 45 818 48
Race
White 442 83 1,471 86
Black or African American 46 9 78 5
Asian or Paciﬁc Islander 35 7 119 7
American Indian or Alaskan Native or Other 9 2 33 2
Hispanic ethnicity
Yes 25 5 114 7
No 507 95 1,585 93
Body mass index (WHO), kg/m
2
\25.0 280 53 993 58
25.0–29.9 197 37 552 33
C30 52 10 147 9
Smoking
Never 163 31 652 38
Cigarette
Former, quit[15 years ago 133 25 508 30
Former, quit 1–15 years ago 89 17 260 15
Current 131 25 208 12
Pipe/cigar 16 3 73 4
Education
\High school 71 13 162 10
High school 164 31 372 22
Some college 200 38 754 44
Graduate school 97 18 413 24
History of diabetes mellitus
No 455 86 1,538 90
Yes 76 14 161 10
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123consumption and risk for pancreatic cancer was observed
among women.
Discussion
Our results have demonstrated that heavy alcohol con-
sumption and binge drinkingwere associated with increased
risk estimates for pancreatic cancer in men but not among
women. Our data further suggested that either binge or
consistent heavy alcohol consumption was associated with
persistent increased risk of pancreatic cancer regardless of
the temporal proximity of consumption to pancreatic cancer
diagnosis. Results from smoking-stratiﬁed analyses that
suggested a possible interaction between current smoking
and heavy drinking should be interpreted with caution and
require further validation in larger pooled studies, particu-
larly given that the p-interactions for these analyses were
[0.3. The association between alcohol consumption and
pancreaticcancerinearlierstudieshasbeendiscordant,with
Table 2 Association between alcohol consumption and pancreatic cancer in a population-based case–control Study in the San Francisco Bay
Area, California, 1995–1999
Men Women
Case
(%)
Control
(%)
OR
a
(95% CI)
OR
b
(95% CI)
Case
(%)
Control
(%)
OR
a
(95% CI)
OR
b
(95% CI)
Dose and duration of alcohol consumption
Never or\1 drink/month (referent) 22 (8) 102 (12) 1.0 1.0 61 (25) 201 (25) 1.0 1.0
Lifetime, drinks/week
B7 102 (35) 358 (41) 1.4 (0.8, 2.3) 1.5 (0.9, 2.6) 127 (53) 461 (56) 0.9 (0.6, 1.3) 1.1 (0.7, 1.6)
8–14 47 (16) 185 (21) 1.2 (0.7, 2.2) 1.4 (0.7, 2.5) 32 (13) 92 (11) 1.1 (0.7, 1.8) 1.2 (0.7, 2.2)
15–21 (men)/[15/week (women) 34 (12) 97 (11) 1.7 (0.9, 3.1) 1.5 (0.8, 2.9) 13 (5) 57 (7) 0.7 (0.4, 1.4) 0.8 (0.4, 1.6)
22–35 (men) 47 (16) 89 (10) 2.4 (1.3, 4.3) 1.9 (1.0, 3.7)
[35 (men) 34 (12) 49 (6) 3.4 (1.8, 6.5) 2.2 (1.1, 4.6)
p-Trend p < 0.0001 p = 0.04 p = 0.7 p = 0.9
Past 20 years, drinks/week
B7 104 (36) 362 (41) 1.4 (0.8, 2.4) 1.5 (0.9, 2.6) 122 (52) 436 (53) 0.9 (0.6, 1.3) 1.1 (0.7, 1.6)
8–14 47 (16) 188 (21) 1.2 (0.7, 2.1) 1.3 (0.7, 2.4) 36 (15) 104 (13) 1.1 (0.7, 1.8) 1.2 (0.7, 2.1)
15–21 (men)/[15/week (women) 32 (11) 97 (11) 1.6 (0.9, 2.9) 1.4 (0.7, 2.7) 14 (6) 70 (9) 0.6 (0.3, 1.2) 0.7 (0.3, 1.4)
22–35 (men) 41 (14) 77 (9) 2.4 (1.3, 4.4) 2.1 (1.1, 4.0)
[35 (men) 40 (14) 54 (6) 3.6 (1.9, 6.7) 2.6 (1.3, 5.1)
p-Trend p < 0.0001 p = 0.01 p = 0.4 p = 0.6
Decades with[21 drink/week
\1 149 (51) 535 (61) 1.4 (0.8–2.2) 1.5 (0.9–2.5) 159 (66) 549 (67) 0.9 (0.7–1.3) 1.1 (0.7–1.6)
1–2 48 (16) 135 (15) 1.7 (1.0–3.1) 1.5 (0.8–2.9) 10 (4) 39 (4) 0.8 (0.4–1.8) 1.0 (0.4–2.2)
C3 68 (23) 108 (12) 2.9 (1.7–5.1) 2.1 (1.1–4.0) 4 (2) 24 (3) –
c –
c
p-Trend p < 0.0001 p = 0.02 p = 0.3 p = 0.5
Decades with[35 drink/week
\1 195 (67) 660 (75) 1.4 (0.9–2.4) 1.5 (0.9–2.6) 166 (69) 585 (72) 0.9 (0.7–1.3) 1.1 (0.7–1.6)
1–2 37 (13) 80 (9) 2.2 (1.2–4.0) 1.6 (0.8–3.2) 7 (3) 22 (3) 1.0 (0.4–2.5) 1.0 (0.4–2.6)
C3 32 (11) 38 (4) 4.0 (2.0–7.8) 2.7 (1.3–5.6) 0 (0) 5 (1) –
c –
c
p-Trend p < 0.0001 p = 0.01 –
c –
c
CI, conﬁdence interval; OR, odds ratio; n/a, not applicable due to sparse data
Bold indicates that 95% conﬁdence interval for point estimate did not cross 1, or p value\0.05
a Adjusted for age (in 5-year group)
b Additionally adjusted for energy intake (kcal/day, men: quartiles, women: quartiles), body mass index (\25, 25.0–29.9, C30 kg/m2), race
(white, black/African American, Asian/Paciﬁc Islander, Others), education (\high school, high school, 1–4 years college, graduate school),
smoking (never smoker, former cigarette smoker who had quit smoking[15 years previously, former cigarette smoker who had quit smoking
1–15 years previously, current cigarette smoker or former cigarette smoker who had quit\1 year previously, pipe and/or cigar smoker), binge
drinking, history of diabetes (yes, no), and physical activity (30-min moderate exercise:\1 month, 1–4/month, 2–6/week, and daily)
c OR and CI are not presented when B5 observations were noted
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123some hospital-based [24–28, 54–59] and population-based
case–control [3, 5, 6, 8, 10, 11, 13, 14, 17, 19, 31, 60] and
cohort studies [4, 7, 9, 32, 33, 38, 42, 61, 62] showing no
association, and other hospital-based [29, 30] and popula-
tion-based case–control [15, 16, 18] and cohort [20, 21, 34,
36, 37, 41, 63] studies suggesting increased risk. Discordant
observations in the published literature may be due to small
numbers of cases, residual confounding by risk factors
associated with alcohol consumption such as smoking and
chronic pancreatitis, unmeasured genetic factors, or absence
of detailed data on alcohol exposure [16, 17, 23, 34, 39].
Discordant results due to residual confounding associ-
ated with smoking are less likely given that, as one of the
few identiﬁed risk factors, most epidemiologic studies have
included tobacco use in their analyses of alcohol con-
sumption and pancreatic cancer risk. Indeed, in several
studies that reported a positive association between alcohol
and pancreatic cancer, the association persisted even among
non-smokers [16, 17, 20, 36]. In our study, data were con-
sistent with persistent increased risk among non-smokers,
but not statistically signiﬁcant. Notably, the number of
never smokers available for analysis in our study required
Table 3 Association between ‘‘binge’’ drinking (irregular alcohol consumption of C5 drinks (70 g alcohol) per day) and pancreatic cancer
among men in a population-based case–control study in the San Francisco Bay Area, California, 1995–1999
Case (%) Control (%) OR
a (95% CI) OR
b (95% CI)
Pattern of drinking
Life time alcohol consumption: Never or\1 drink/month (referent) 22 (8) 102 (12) 1.0 1.0
Lifetime binge alcohol consumption C1/month 64 (22) 119 (13) 2.5 (1.4, 4.4) 3.5 (1.6, 7.5)
First age at binge drinking, years
B20 19 (7) 43 (5) 2.0 (1.0–4.3) 2.9 (1.1–7.4)
21–30 20 (7) 36 (4) 2.5 (1.2–5.2) 4.3 (1.7–11)
31–40 25 (9) 40 (5) 2.9 (1.5–5.8) 3.4 (1.4–8.4)
p-trend p = 0.002 p = 0.007
Interval between last binge drinking and diagnosis
for cases or interview for controls, years
0–5 18 (6) 34 (4) 2.4 (1.1–5.2) 3.4 (1.3–8.9)
6–10 13 (4) 14 (16) 4.7 (1.9–12) 6.3 (2.0–20)
[10 33 (11) 70 (8) 2.2 (1.2–4.1) 3.0 (1.3–7.0)
Drinks/day during binge drinking
5–9 31 (11) 74 (8) 2.0 (1.0–3.7) 3.1 (1.3–7.3)
10–14 15 (5) 26 (3) 2.6 (1.1–5.8) 3.6 (1.3–9.7)
[14 18 (6) 19 (2) 4.3 (1.9–9.7) 4.4 (1.4–13)
p-trend p = 0.0002 p = 0.002
Frequency of binge drinking
B1/month 27 (9) 42 (5) 3.0 (1.5–5.9) 4.3 (1.8–10)
2–3/month 13 (4) 30 (3) 2.0 (0.9–4.5) 3.0 (1.1–8.6)
[3/month 24 (8) 45 (5) 2.4 (1.2–4.9) 3.0 (1.2–7.4)
p-trend p = 0.02 p = 0.06
Duration of binge drinking, years
1–5 12 (4) 28 (3) 2.1 (0.9–5.0) 2.3 (0.8–6.8)
6–10 13 (4) 31 (4) 1.7 (0.9–4.5) 2.9 (1.1–7.8)
[10 39 (13) 60 (7) 2.9 (1.5–5.4) 3.7 (1.9–11)
p-trend p = 0.001 p = 0.0006
CI, conﬁdence interval; OR, odds ratio
Bold indicates that 95% conﬁdence interval for point estimate did not cross 1, or p value\0.05
a Adjusted for age (in 5-year group)
b Additionally adjusted for energy intake (kcal/day, men: quartiles, women: quartiles), body mass index (\25, 25.0–29.9, C30 kg/m2), race
(white, black/African American, Asian/Paciﬁc Islander, others), education (\high school, high school, 1–4 years college, graduate school),
smoking (never smoker, former cigarette smoker who had quit smoking[15 years previously, former cigarette smoker who had quit smoking
1–15 years previously, current cigarette smoker or former cigarette smoker who had quit\1 year previously, pipe and/or cigar smoker), lifetime
alcohol consumption, history of diabetes (yes, no), and physical activity (30-min moderate exercise each time:\1 month, 1–4/month, 2–6/week,
and daily)
1052 Cancer Causes Control (2010) 21:1047–1059
123Table 4 Association between alcohol consumption and pancreatic cancer among men, stratiﬁed by smoking status, in a population-based
case–control study in the San Francisco Bay Area, California, 1995–1999
Non-smokers
a Smokers
b
Case
(%)
Control
(%)
OR
c
(95% CI)
OR
d
(95% CI)
Case
(%)
Control
(%)
OR
c
(95% CI)
OR
d
(95% CI)
Dose and duration of alcohol consumption
Never or\1 drink/month (referent) 17 (11) 81 (14) 1.0 1.0 5 (8) 10 (5) 1.0 1.0
Lifetime, drinks/week
5–7 68 (45) 232 (41) 1.4 (0.8, 2.5) 1.5 (0.8, 2.7) 21 (33) 85 (41) 0.5 (0.2, 1.6) 0.6 (0.2, 2.4)
8–14 27 (18) 121 (22) 1.1 (0.5, 2.1) 1.2 (0.6, 2.4) 6 (10) 46 (22) 0.3 (0.1, 1.0) 0.4 (0.1, 1.6)
15–21 15 (10) 57 (10) 1.3 (0.6, 2.8) 1.2 (0.5, 2.7) 9 (14) 26 (13) 0.7 (0.2, 2.6) 0.9 (0.2, 3.9)
22–35 14 (9) 43 (8) 1.6 (0.7, 3.5) 1.4 (0.6, 3.2) 13 (21) 28 (14) 0.9 (0.3, 3.3) 1.2 (0.3, 4.9)
[35 6 (4) 25 (4) 1.2 (0.4, 3.3) 0.8 (0.3, 2.4) 9 (14) 10 (5) 1.8 (0.4, 7.3) 2.2 (0.5, 9.9)
p-trend 0.7 0.7 0.3 0.3
Past 20 years, drinks/week
B7 69 (46) 232 (41) 1.4 (0.8, 2.5) 1.5 (0.8, 2.7) 18 (29) 87 (42) 0.4 (0.1, 1.4) 0.6 (0.2, 2.1)
8–14 25 (17) 126 (23) 0.9 (0.5, 1.8) 1.0 (0.5, 2.0) 11 (17) 46 (22) 0.5 (0.1, 1.7) 0.7 (0.2, 2.8)
15–21 12 (8) 54 (10) 1.1 (0.5, 2.4) 1.1 (0.5, 2.4) 9 (14) 25 (12) 0.7 (0.2, 2.7) 1.0 (0.2, 4.0)
22–35 13 (9) 38 (7) 1.6 (0.7, 3.7) 1.5 (0.7, 3.6) 11 (17) 25 (12) 0.9 (0.2, 3.2) 1.2 (0.3, 4.8)
[35 11 (7) 28 (5) 1.9 (0.8, 4.5) 1.5 (0.6, 3.8) 9 (14) 12 (6) 1.5 (0.4, 5.9) 1.8 (0.4, 8.1)
p-trend 0.4 0.4 0.3 0.3
Decades with[21 drink/week
\1 92 (61) 352 (63) 1.2 (0.7, 2.2) 1.4 (0.8, 2.5) 30 (48) 127 (62) 0.5 (0.2, 1.5) 0.6 (0.2, 2.3)
1–2 21 (14) 64 (11) 1.6 (0.8, 3.2) 1.5 (0.7, 3.2) 10 (16) 46 (22) 0.4 (0.1, 1.5) 0.6 (0.1, 2.2)
C3 17 (11) 62 (11) 1.3 (0.6, 2.7) 1.1 (0.5, 2.4) 18 (29) 22 (11) 1.8 (0.5, 6.3) 2.3 (0.6, 8.8)
p-trend 0.4 0.8 0.02 0.03
Decades with[35 drink/week
\1 113 (75) 422 (75) 1.3 (0.7, 2.2) 1.4 (0.8, 2.4) 40 (63) 163 (79) 0.5 (0.2, 1.5) 0.7 (0.2, 2.4)
1–2 9 (6) 35 (6) 1.2 (0.5, 3.0) 1.1 (0.4, 2.8) 9 (14) 27 (13) 0.7 (0.2, 2.4) 0.9 (0.2, 3.5)
C3 8 (5) 21 (4) 1.8 (0.7, 4.8) 1.4 (0.5, 3.8) 9 (14) 5 (2) 3.9 (0.8, 18.1) 4.7 (0.9, 24.1)
p-trend 0.3 0.6 0.01 0.02
Pattern of drinking
Lifetime binge alcohol
consumption C 1/month
24 (59) 64 (44) 1.8 (0.9, 3.7) 1.7 (0.8, 3.7) 15 (75) 27 (73) 1.1 (0.3, 3.8) 1.9 (0.4, 8.9)
First age at binge drinking, years
B20 9 (22) 22 (15) 2.1 (0.8, 5.4) 2.1 (0.7, 6.1) 3 (15) 12 (32) –
e –
e
21–30 9 (22) 19 (13) 2.3 (0.9, 6.0) 2.4 (0.9, 6.5) 5 (25) 8 (22) 1.1 (0.2, 5.5) 2.9 (0.4, 21)
31–40 6 (15) 23 (16) 1.2 (0.4, 3.5) 1.1 (0.4, 3.2) 7 (35) 7 (19) 2.1 (0.5, 9.4) 4.3 (0.6, 29.4)
p-trend 0.3 0.5 –
e –
e
Interval between last binge drinking and diagnosis for cases or interview for controls, years
0–5 10 (24) 14 (10) 3.9 (1.4, 10.6) 3.6 (1.2, 10.4) 4 (20) 7 (19) –
e –
e
6–10 3 (7) 8 (6) –
e –
e 3 (15) 3 (8) –
e –
e
[10 11 (27) 42 (29) 1.3 (0.5, 2.9) 1.2 (0.5, 3.0) 8 (40) 17 (46) 0.9 (0.2, 3.6) 1.3 (0.2, 7.1)
p-trend –
e –
e
Drinks/day during binge drinking
5–9 14 (34) 46 (32) 1.5 (0.7, 3.3) 1.5 (0.6, 3.4) 6 (30) 15 (41) 0.7 (0.2, 3.2) 1.1 (0.2, 6.9)
10–14 7 (17) 12 (8) 2.9 (1.0, 8.5) 2.8 (0.9, 8.9) 3 (15) 6 (16) –
e –
e
[14 3 (7) 6 (4) –
e –
e 6 (30) 6 (16) 2.0 (0.4, 9.7) 3.9 (0.6, 25.2)
p-trend –
e –
e –
e –
e
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123pooling of data from never smokers with those who quit
smoking over 15 years prior to interview; this may have
biased our estimates comparing risk among non-smokers to
smokers toward ﬁnding a smaller risk difference than
actually present. However, because there was a small
sample of never smokers, and the ability to adjust for more
detailed smoking characteristics (such as pack-years of
smoking) was limited, it is possible that residual con-
founding due to smoking cannot be completely excluded.
Unmeasured molecular and genetic characteristics
within individuals and their cancers also may explain some
discordant observations. For example, particular mutations
in the K-ras oncogene may be more common in alcohol
consumers with pancreatic cancers, and may be initiating
or end mediators of pancreas cancer associated with heavy
alcohol exposure [23, 64, 65].
Misclassiﬁcation of alcohol consumption related to
recall bias or inadequate measurement of detailed alcohol
consumption over time may be a more likely explanation
for the discordant published results. The potential for recall
bias is inherent to all retrospective studies and also has
been noted in several prospective cohort studies [9, 10, 12,
20, 21]. The extensive measures taken in our study to
diminish the effects of recall bias are noted below.
Measurement error with respect to characterization of the
dose, duration, and pattern of alcohol consumption may
explain some discordant ﬁndings between alcohol
consumption and pancreatic cancer risk [40]. Few popula-
tion-based studies have analyzed the relationship between
pancreas cancer and binge alcohol consumption [6, 14, 16,
61]. Of these, one study observed that increased risks were
mainlyinthehighestcategoriesofalcoholconsumption,and
were stronger among African Americans than for whites
[16]. Although the authors reported no association between
pancreatic cancer and binge drinking [16], the deﬁnition of
binge drinking that was used (C3 drinks/week) was lower
than that used in our analyses based upon the United States
Behavioral Risk Factor Surveillance System study [50, 51].
Our observation that binge drinking (C5 drinks/episode,
[70 g of alcohol)—even when occurring years before
diagnosis or among moderate alcohol consumers—was
associated with increased cancer risk, suggests that the
pattern of drinking may be an important mediator of effect.
Averaging alcohol exposure over weeks, months, or years,
classifying consumption into broad categories, and/or
computing lifetime alcohol exposures to measure total
consumption, may not accurately assess toxicity that results
from high and/or binge doses of alcohol. Thus, use of these
methods may limit the ability to identify associations
between alcohol exposure and pancreatic cancer.
Several biologic mechanisms have been proposed to
explain the observed increased risk of pancreatic cancer
Table 4 continued
Non-smokers
a Smokers
b
Case
(%)
Control
(%)
OR
c
(95% CI)
OR
d
(95% CI)
Case
(%)
Control
(%)
OR
c
(95% CI)
OR
d
(95% CI)
Frequency of binge drinking
B1/month 9 (22) 24 (17) 1.8 (0.7, 4.6) 1.7 (0.6, 4.6) 8 (40) 9 (24) 1.7 (0.4, 7.3) 3.7 (0.6, 22.8)
2–3/month 7 (17) 19 (13) 1.8 (0.7, 5.1) 1.8 (0.6, 5.5) 2 (10) 7 (19) –
e –
e
[3/month 8 (20) 20 (14) 1.9 (0.7, 5.2) 1.8 (0.6, 5.0) 5 (25) 11 (30) 0.9 (0.2, 4.0) 1.3 (0.2, 7.8)
p-trend 0.1 0.1 –
e
Duration of binge drinking, years
1–5 5 (12) 15 (10) 1.6 (0.5, 5.2) 1.4 (0.4, 4.8) 2 (10) 6 (16) –
e –
e
6–10 5 (12) 18 (12) 1.3 (0.4, 4.1) 1.2 (0.4, 3.8) 2 (10) 3 (8) –
e –
e
[10 14 (34) 31 (21) 2.2 (1.0, 5.0) 2.3 (0.9, 5.5) 11 (55) 18 (49) 1.2 (0.3, 4.4) 2.5 (0.5, 13.1)
p-trend 0.07 0.09 –
e –
e
CI, conﬁdence interval; OR, odds ratio
Bold indicates that 95% conﬁdence interval for point estimate did not cross 1, or p value\0.05
a Non-smoker group includes lifetime non-smokers, as well as smokers who quit[15 years prior to interview
b Smoker group includes current cigarette, pipe, and/or cigar smokers and those who quit B15 years prior to interview
c Adjusted for age (continuous)
d Additionally adjusted for energy intake (kcal/day, men: 50 percentile), body mass index (\25, C25.0 kg/m
2), race (white, black/African
American, and Asian/Paciﬁc Islander/others), binge drinking (in models of lifetime alcohol consumption), lifetime alcohol consumption (in
models of binge drinking), education (\=high school, 1–4 years college/graduate), history of diabetes (yes, no), and physical activity (30-min
moderate exercise:\4/month, C2/week)
e OR and CI not presented when B5 observations
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123Table 5 Association between alcohol consumption and pancreatic cancer among male current smokers in a population-based case–control study
in the San Francisco Bay Area, California, 1995–1999
Male current smokers
Case (%) Control (%) OR
a (95% CI) OR
b (95% CI)
Dose and duration of alcohol consumption
Lifetime\1 drink/month or past 20 years prior
to interview B 4 drinks/week (referent)
12 (16) 39 (33) 1.0 1.0
Lifetime, drinks/week
B14 15 (19) 31 (26) 1.6 (0.6, 3.8) 1.6 (0.6, 4.0)
15–21 10 (13) 14 (12) 2.3 (0.8, 6.5) 2.3 (0.8, 6.9)
22–35 20 (26) 18 (15) 3.6 (1.5, 9.1) 3.1 (1.2, 7.9)
[35 19 (25) 14 (12) 4.4 (1.7, 11) 4.1 (1.5, 11)
p-trend 0.003 0.02
Past 20 years, drinks/week
5–14 16 (21) 31 (26) 1.7 (0.7, 4.1) 1.7 (0.7, 4.3)
15–21 11 (14) 18 (15) 2.0 (0.7, 5.4) 1.7 (0.6, 4.9)
22–35 17 (22) 14 (12) 4.0 (1.5, 10) 3.5 (1.3, 9.4)
[35 20 (26) 14 (12) 4.6 (1.8, 12) 4.2 (1.6, 12)
p-trend 0.003 0.002
Decades with[21 drink/week
\1 16 (21) 30 (26) 1.7 (0.7, 4.1) 1.5 (0.6, 3.9)
1–2 16 (21) 23 (20) 2.2 (0.9, 5.4) 2.3 (0.9, 6.0)
C3 33 (43) 24 (21) 4.6 (2.0, 11) 4.1 (1.7, 9.9)
p-trend 0.0002 0.001
Decades with[35 drink/week
\1 32 (42) 47 (40) 2.2 (1.0, 4.9) 2.0 (0.9, 4.6)
1–2 18 (23) 18 (15) 3.2 (1.3, 8.1) 3.2 (1.2, 8.4)
C3 15 (19) 12 (10) 4.1 (1.5, 11) 3.6 (1.2, 10)
p-trend .03 0.08
Pattern of drinking
Lifetime binge alcohol consumption[1/month 21 (84) 23 (59) 3.8 (1.1, 14) 5.2 (1.2, 22)
First age at binge drinking, years
B20 6 (24) 6 (15) 3.9 (0.8, 19) 5.0 (0.8, 30)
21–30 4 (16) 9 (23) –
C –
C
31–40 11 (44) 8 (21) 5.1 (1.2, 21) 6.6 (1.3, 35)
p-trend –
C –
C
Interval between last binge drinking and diagnosis
for cases or interview for controls, years
0–5 4 (16) 10 (26) 1.8 (0.3, 9.1) 1.7 (0.3, 11)
6–10 7 (28) 3 (8) –
C –
C
[10 10 (40) 9 (23) 4.5 (1.0, 19) 8.7 (1.5, 51)
p-trend –
C –
C
Drinks/day during binge drinking
5–9 7 (28) 9 (23) 3.6 (0.8, 17) 3.9 (0.7, 22)
10–14 5 (20) 8 (21) 2.5 (0.5, 12) 4.2 (0.7, 25)
[14 9 (36) 6 (15) 5.6 (1.2, 26) 9.5 (1.4, 64)
p-trend 0.03 0.01
Frequency of binge drinking
B1/month 7 (28) 6 (15) 4.5 (0.9, 22) 5.2 (0.9, 31)
2–3/month 4 (16) 4 (10) –
C –
C
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123related to heavy alcohol consumption. Alcohol may initiate
inﬂammatory responses that result in overt chronic pan-
creatitis or diabetes mellitus, perhaps via induction of
mitogenic stimuli [22, 23]. Alcohol consumption also may
lead to asymptomatic chronic pancreatitis that then leads to
pancreatic cancer [66–71], although the prevalence of the
history of pancreatitis is small in the overall population of
pancreatic cancer patients. In addition, oxidative and non-
oxidative pancreatic damage due to metabolism of alcohol
can initiate inﬂammatory and ﬁbrotic cascades that may
result in subsequent carcinogenesis [22]. Further detailed
study of alcohol consumption, including dose, duration,
and pattern of exposure, is needed to discern the biologic
mechanisms that are important in pancreatic cancer
development.
A null or protective association for alcohol and pan-
creatic cancer among women has been noted in most, [6, 9,
10, 14, 17, 24, 27, 28, 36, 38, 39, 41, 42, 55, 56, 59, 61, 62],
but not all [16, 20, 34, 37] earlier studies. In our study, the
proportion of women who reported heavy and/or binge
drinking was much lower than for men. Therefore, the lack
of an observed association may be attributable to sample
size constraints. Further research is necessary to understand
differences in pancreatic cancer risk between men and
women.
Possible limitations of case–control studies should be
considered when interpreting our results. Recall bias may
be a problem in studies that query people about past events,
although the effects of recall bias may have been dimin-
ished by requesting that participants report detailed alcohol
consumption in multiple ways and over multiple time
periods. Interviewers were highly trained and monitored to
avoid interviewer bias and data were collected using a
standardized questionnaire that included recent and past
exposures. Because our results showed consistent trends
between pancreatic cancer and dose and duration of alcohol
exposure and, as noted earlier, underreporting would have
diminished the risk estimates toward the null, recall bias
may have had limited inﬂuence. Although rapid case
ascertainment methods were used, similar to other popu-
lation-based studies of pancreatic cancer, a large number of
patients had died prior to initial contact due to the
aggressive nature of the disease. The potential effect of
these non-interviewed patients on risk estimates is
unknown, as alcohol consumption data were not available
for non-interviewed cases who died shortly after diagnosis.
Our prior comparison of demographic data from SEER
abstracts for interviewed and non-interviewed cases who
were identiﬁed as part of our study showed that non-
interviewed cases tended to be slightly older, with a
slightly greater proportion of women than men, somewhat
more minorities, fewer known tumor characteristics, and
shorter survival times [44].
In summary, our ﬁndings support an association
between heavy alcohol consumption and pancreatic cancer
among men that may be mediated by dose, duration, and
pattern of alcohol consumption, including binge drinking.
If the observed relationship with heavy alcohol consump-
tion and binge drinking is conﬁrmed by other large studies
that have collected detailed alcohol exposure data, targeted
interventions to reduce heavy drinking and binge drinking
(which is prevalent and increasing in frequency [51, 72])
may be of even greater importance than previously rec-
ognized. The difﬁculty of early diagnosis, and the rapid
Table 5 continued
Male current smokers
Case (%) Control (%) OR
a (95% CI) OR
b (95% CI)
[3/month 10 (40) 12 (31) 3.8 (0.9, 16) 5.0 (1.0, 26)
p-trend 0.1 0.06
Duration of binge drinking, years
1–5 3 (12) 5 (13) –
C –
C
6–10 5 (20) 10 (26) 2.1 (0.4, 10) 2.8 (0.5, 17)
[10 13 (52) 8 (21) 6.2 (1.5, 26) 9.5 (1.8, 50)
p-trend –
C –
C
CI, conﬁdence interval; OR, odds ratio
Bold indicates that 95% conﬁdence interval for point estimate did not cross 1, or p value\0.05
a Adjusted for age (continuous)
b Additionally adjusted for energy intake (kcal/day, men: 50 percentile), body mass index (\25, C25.0 kg/m2), race (white, black/African
American, and Asian/Paciﬁc Islander/others), education (Bhigh school, 1–4 years college/graduate), binge drinking (in models of lifetime
alcohol consumption), lifetime alcohol consumption (in models of binge drinking), history of diabetes (yes, no), and physical activity (30-min
moderate exercise:\4/month, C2/week)
C OR and CI not presented when B5 observations
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123progression from diagnosis to death calls for concerted
cancer prevention efforts to identify and intervene on all
potentially modiﬁable risk factors for pancreatic cancer,
including alcohol consumption.
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